Medical literature, vena cava filters and evidence of efficacy

Summary

Up to 15% of all patients with venous thromboembolism (VTE) receive an inferior vena cava filter, and prophylactic placements are increasing. To determine whether current use of filters is based on robust evidence, a global review of the recent (2001–2012) literature on filters was undertaken. The MEDLINE database was searched for articles related to filters appearing during the period 2001–2012, updating a prior search of literature from 1975–2001. All retrieved articles were analysed, classified into predetermined categories and compared to the prior analysis; randomised and large (>100 patients with a filter) comparative non-randomised clinical studies were read in full. The 651 articles, vs 568 in the period 1975–2000, consisted mainly of retrospective series (37.8%), case reports (31.7%), reviews (14.7%, vs 6.7%, p<0.001), animal and/or in vitro studies (7.5%, vs 12.9%, p=0.002), and prospective series or trials (4.9%, vs 7.4%, p=0.07). Of 4 new randomised trials (RCT), none were designed to test the efficacy of the device; to date, only one RCT has attempted to ascertain efficacy, occurring during the period 1975–2000. Eleven large non-randomised studies compared clinical outcomes of patients with and without filters, in VTE patients (n=5) or prophylactic indications (n=6); two studies found statistically significant relationships between filter use and lower mortality rates, though none could demonstrate a causal relationship. Hence, the plethoric literature on filters parallels growing experience with these devices, but still fails to provide reliable evidence that filter use improves relevant clinical outcomes. No indication for filter placement is based on appropriate scientific evidence.

Keywords

Vena cava filters - pulmonary embolism - venous thrombosis - treatment outcome

• References

• 1 Falck-Ytter Y, Francis CW, Johanson NA. et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.. Chest 2012; 141 (Suppl. 02) e278S-325S.
• 2 Gould MK, Garcia DA, Wren SM. et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.. Chest 2012; 141 (Suppl. 02) e227S-77S.
• 3 Kahn SR, Lim W, Dunn AS. et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.. Chest 2012; 141 (Suppl. 02) e195S-226S.
• 4 Kearon C, Akl EA, Comerota AJ. et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.. Chest 2012; 141 (Suppl. 02) e419S-94S.
• 5 Minichiello T. Efforts to optimize patient benefit from inferior vena cava filters: comment on “Retrieval of inferior vena caval filters after prolonged indwelling time”.. Arch Intern Med 2011; 171: 1955-1956.
• 6 Girard P, Stern JB, Parent F. Medical literature and vena cava filters: so far so weak.. Chest 2002; 122: 963-967.
• 7 Decousus H, Leizorovicz A, Parent F. et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prevention du Risque d’Embolie Pulmonaire par Interruption Cave Study Group [see comments].. N Engl J Med 1998; 338: 409-415.
• 8 Prasad V, Rho J, Cifu A. The inferior vena cava filter: how could a medical device be so well accepted without any evidence of efficacy?. JAMA Intern Med 2013; 173: 493-495.
• 9 Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d’Embolie Pulmonaire par Interruption Cave) randomised study.. Circulation 2005; 112: 416-422.
• 10 Hann CL, Streiff MB. The role of vena caval filters in the management of venous thromboembolism.. Blood Rev 2005; 19: 179-202.
• 11 Monreal M, Falga C, Valdes M. et al. Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry.. J Thromb Haemost 2006; 4: 1950-1956.
• 12 Jaff MR, Goldhaber SZ, Tapson VF. High utilization rate of vena cava filters in deep vein thrombosis.. Thromb Haemost 2005; 93: 1117-1119.
• 13 Yunus TE, Tariq N, Callahan RE. et al. Changes in inferior vena cava filter placement over the past decade at a large community-based academic health center.. J Vasc Surg 2008; 47: 157-165.
• 14 Moore PS, Andrews JS, Craven TE. et al. Trends in vena caval interruption.. J Vasc Surg 2010; 52: 118-125 e 3; discussion 125-126.
• 15 Shackford SR, Cook A, Rogers FB. et al. The increasing use of vena cava filters in adult trauma victims: data from the American College of Surgeons National Trauma Data Bank.. J Trauma 2007; 63: 764-769.
• 16 Stein PD, Matta F, Hull RD. Increasing use of vena cava filters for prevention of pulmonary embolism.. Am J Med 2011; 124: 655-661.
• 17 White RH, Geraghty EM, Brunson A, Murin S, Wun T, Spencer FA. et al. High variation between hospitals in vena cava filter use for venous thromboembol-ism.. JAMA Internal Med 2013; (issue) 1-7.
• 18 Wells GA. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses.. http://wwwohrica/programs/clini-calepidemiology/oxfordhtm Last accessed May 13, 2013.
• 19 Maxwell L, Santesso N, Tugwell PS. et al. Method guidelines for Cochrane Mus-culoskeletal Group systematic reviews.. J Rheumatol 2006; 33: 2304-2311.
• 20 Barginear MF, Gralla RJ, Bradley TP. et al. Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomised clinical trial.. Support Care Cancer 2012; 20: 2865-2872.
• 21 Rajasekhar A, Lottenberg L, Lottenberg R. et al. A pilot study on the randomization of inferior vena cava filter placement for venous thromboembolism prophylaxis in high-risk trauma patients.. J Trauma 2011; 71: 323-329.
• 22 Usoh F, Hingorani A, Ascher E. et al. Prospective randomised study comparing the clinical outcomes between inferior vena cava Greenfield and TrapEase filters.. J Vasc Surg 2010; 52: 394-399.
• 23 Xiao L, Huang DS, Shen J, Tong JJ. Introducer curving technique for the prevention of tilting of transfemoral Gunther Tulip inferior vena cava filter.. Korean J Radiol 2012; 13: 483-491.
• 24 Mismetti P, Ennezat P-V, Quéré I. et al. Prevention of pulmonary embolism recurrences by retrievable vena cava filter: results of the randomised multicenter trial PREPIC 2.. J Thromb Haemost 2013; 11 (Suppl. 02) 28 (abstract avalaible at http://www.isth2013.org ).
• 25 Young T, Tang H, Hughes R. Vena caval filters for the prevention of pulmonary embolism.. Cochrane Database Syst Rev 2010; CD006212.
• 26 Billett HH, Jacobs LG, Madsen EM. et al. Efficacy of inferior vena cava filters in anticoagulated patients.. J Thromb Haemost 2007; 5: 1848-1853.
• 27 Obeid FN, Bowling WM, Fike JS. et al. Efficacy of prophylactic inferior vena cava filter placement in bariatric surgery.. Surg Obes Relat Dis 2007; 3: 606-610.
• 28 Ozturk C, Ganiyusufoglu K, Alanay A. et al. Efficacy of prophylactic placement of inferior vena cava filter in patients undergoing spinal surgery.. Spine 2010; 35: 1893-1896.
• 29 Birkmeyer NJ, Share D, Baser O. et al. Preoperative placement of inferior vena cava filters and outcomes after gastric bypass surgery.. Ann Surg 2010; 252: 313-318.
• 30 Spencer FA, Bates SM, Goldberg RJ. et al. A population-based study of inferior vena cava filters in patients with acute venous thromboembolism.. Arch Intern Med 2010; 170: 1456-1462.
• 31 Stein PD, Matta F, Keyes DC. et al. Impact of vena cava filters on in-hospital case fatality rate from pulmonary embolism.. Am J Med 2012; 125: 478-484.
• 32 Sakuma M, Nakamura M, Nakanishi N. et al. Inferior vena cava filter is a new additional therapeutic option to reduce mortality from acute pulmonary embolism.. Circ J 2004; 68: 816-821.
• 33 Ghanim AJ, Daskalakis C, Eschelman DJ. et al. A five-year, retrospective, comparison review of survival in neurosurgical patients diagnosed with venous thromboembolism and treated with either inferior vena cava filters or anticoagulants.. J Thromb Thrombolysis 2007; 24: 247-254.
• 34 Overby DW, Kohn GP, Cahan MA. et al. Risk-group targeted inferior vena cava filter placement in gastric bypass patients.. Obes Surg 2009; 19: 451-455.
• 35 Li W, Gorecki P, Semaan E. et al. Concurrent prophylactic placement of inferior vena cava filter in gastric bypass and adjustable banding operations in the Bari-atric Outcomes Longitudinal Database.. J Vasc Surg 2012; 55: 1690-1695.
• 36 Batty LM, Lyon SM, Dowrick AS. et al. Pulmonary embolism and the use of vena cava filters after major trauma.. ANZ J Surg 2012; 82: 817-821.
• 37 Owens CA, Bui JT, Knuttinen MG. et al. Intracardiac migration of inferior vena cava filters: review of published data.. Chest 2009; 136: 877-887.
• 38 Nicholson W, Nicholson WJ, Tolerico P. et al. Prevalence of fracture and fragment embolization of Bard retrievable vena cava filters and clinical implications including cardiac perforation and tamponade.. Arch Intern Med 2010; 170: 1827-1831.
• 39 Sano M, Unno N, Yamamoto N. et al. Frequent fracture of TrapEase inferior vena cava filters: a long-term follow-up assessment.. Arch Intern Med 2011; 172: 189-191.
• 40 Geerts WH, Bergqvist D, Pineo GF. et al. Prevention of venous thromboembol-ism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).. Chest 2008; 133 (Suppl. 06) 381S-453S.
• 41 Guyatt GH, Norris SL, Schulman S. et al. Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrom-botic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.. Chest 2012; 141 (Suppl. 02) 53S-70S.
• 42 Stein PD, Matta F. Vena cava filters in hospitalised patients with chronic obstructive pulmonary disease and pulmonary embolism.. Thromb Haemost 2013; 109: 897-900.
• 43 Nieto JA, Camara T, Gonzalez-Higueras E. et al. Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry.. Thromb Haemost 2008; 100: 789-796.
• 44 Jaff MR, McMurtry MS, Archer SL. et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic throm-boembolic pulmonary hypertension: a scientific statement from the American Heart Association.. Circulation 2011; 123: 1788-1830.
• 45 British Committee for Standards in Haematology Writing G. Baglin TP, Brush J, Streiff M. Guidelines on use of vena cava filters.. Br J Haematol 2006; 134: 590-595.
• 46 Geerts WH. Clinical guide—inferior vena cava filters.. http://www.tigc.org/clinical-guides/Inferior-Vena-Cava-Filters/aspx 2009. Last accessed 25 October, 2013.